Clinical Chemistry • Beckman Coulter Diagnostics
Beckman Coulter · Diazyme Human Kappa & Lambda FLC assays
The worldwide incidence of patients with multiple myeloma is increasing due to population aging and growth, making early detection crucial. The levels of Kappa or Lambda Free Light Chains in serum are often abnormal in plasma cell disorders, such as multiple myeloma, Waldenström’s macroglobulinemia, Lymphocytic neoplasms and AL amyloidosis. The Human Kappa and Lambda Free Light Chain (FLC) Assays are intended for the quantitative determination of Kappa Free Light Chain and Lambda Free Light Chain concentration in serum and can be integrated seamlessly on routine AU or DxC/AU analyzers negating the need for a separate platform or batch testing.
- Excellent performance and ease of use with liquid, ready-to-use reagents
- Provides automated screening of serum free light chains for Multiple Myeloma
- Delivers confidence with clinical diagnosis decisions for multiple myeloma
- Available on all Beckman Coulter Clinical Chemistry Analyzers, AU480/AU680, DxC700AU and AU5800 Series stand alone or connected to automation